One participant in the drug trial for Journavx said it eliminated her pain without making her feel loopy or nauseous, which she experienced when taking opioids.

When a drug smuggler busted in Butte, Montana, wouldn’t flip and become an informant, he went on the run. Then a domestic ...

But all of those promises have turned out to be overstated or simply wrong. Legalization has raised cannabis consumption ...

The U.S. Food and Drug Administration (FDA) has approved Journavx, a new pain reliever without the risks of addiction or ...

The backdoor on Contec CMS8000 patient-monitoring devices could allow an IP address at an unnamed university to remotely ...

NORC Center for Public Affairs Research shows about half of U.S. adults believe it is a good thing for adults to use weight-loss drugs like Ozempic, Wegovy and other brands if they are struggling with ...

The medication offers relatively modest pain relief, underscoring the challenges of finding new ways to manage pain.

“I’ve done everything I want to do and gone everywhere I want to go,” Faithfull said in 2013, looking back on her monumental, ...

Shares of weight-loss drug developer Metsera jumped nearly 42% in a strong Nasdaq debut on Friday, valuing the ARCH Venture ...

Suzetrigine prevents pain signals from reaching the brain and doesn't give an opioid-like high, making it non-addictive—but ...

Sen. Elizabeth Warren grilled Robert F. Kennedy Jr. over his plans to profit off of drug companies or lawsuits after being ...

Shares of Maze Therapeutics rose nearly 1% in their Nasdaq debut on Friday, valuing the kidney disease drug developer at $690.37 million.